Designing siRNAs for improving their therapeutic applications
January 27th, 2021
Presenter: Dr. Annabelle Biscans (AstraZeneca)
Small interfering RNAs (siRNAs) have the potential to revolutionize medicine due to their potency, duration of effect, and ability to target previously “undruggable” disease genes.